08:07 AM EDT, 07/22/2025 (MT Newswires) -- Lantheus ( LNTH ) said Tuesday that it has completed the acquisition of Life Molecular Imaging, a subsidiary of Life Healthcare Group.

As part of the acquisition, former CEO of Life Molecular Imaging Ludger Dinkelborg was appointed head of research and development at Lantheus ( LNTH ) effective Aug. 1, the company said.

The company said in January that it agreed to acquire Life Molecular Imaging in an all-cash deal worth up to $750 million.